COVID Olfactory Trial Hints at Possible Benefit

COVID Olfactory Trial Hints at Possible Benefit

4.5
(664)
Escribir comentario
Más
€ 6.50
Añadir al carro
En stock
Descripción

Small sample size limits significance of findings

COVID Olfactory Trial Hints at Possible Benefit

Inflammation, Rather Than Virus Provoking It, May Be Key to COVID-19 Loss of Smell

Doctors Feel Hopeful About Restoring Taste and Smell Loss After Covid

New treatment restores sense of smell in pati

Biomedicines, Free Full-Text

Gabapentin No Help for Lingering COVID-Induced Olfactory Dysfunction

Subcutaneous anti-COVID-19 hyperimmune immunoglobulin for prevention of disease in asymptomatic individuals with SARS-CoV-2 infection: a double-blind, placebo-controlled, randomised clinical trial - eClinicalMedicine

Recruitment underway for clinical study of PBM for treating long COVID-19

Considerations for diagnostic COVID-19 tests

Full article: Nasal delivery as a strategy for the prevention and treatment of COVID-19

Two Years into the COVID-19 Pandemic: Lessons Learned

Frontiers Follow Your Nose: A Key Clue to Understanding and Treating COVID -19